initiated, funded and developed by Takeda
Adverse Event reporting information can be found at the bottom of the page
initiated, funded and developed by Takeda
Professor Ian Wong presents a comprehensive overview of population-based data exposing the reality of treatment discontinuation in adults with ADHD, including recent insights from the 2025 TIMESPAN study.
He then explores the drivers behind these trends, explaining why maintaining patients on treatment is critical for outcomes, and shares tips to support adherence.